Coronavirus Crisis: A Preventable Pandemic?

Reuters - "Wet Market" is a local slaughterhouse. Animals purchased are slaughtered site on scene

Reuters – “Wet Market” is a local slaughterhouse. Animals purchased are slaughtered site on scene

Animals slaughtered in close proximity to humans, food, and other species creates unsanitary spillover of bacteria, and is a hotbed for cross contamination

Animals slaughtered in close proximity to humans, food, and other species creates unsanitary spillover of bacteria, and is a hotbed for cross contamination

Carissa Kranz, CEO of BeVeg Vegan Certification. Awarded Super Lawyer and vegan law advocate. Upcoming book: Vegan Law: Know Your Rights

Carissa Kranz, CEO of BeVeg Vegan Certification. Awarded Super Lawyer and vegan law advocate. Upcoming book: Vegan Law: Know Your Rights

Global Vegan Certification Symbol by BeVeg. The logo for plant-based food safety and sustainability. Represents sanitary products and conditions uncontaminated by animals. No cross contamination.

Global Vegan Certification Symbol by BeVeg. The logo for plant-based food safety and sustainability. Represents sanitary products and conditions uncontaminated by animals. No cross contamination.

Global vegan trademark for products and services that do not use or exploit animals. Represented on every continent except Antarctica. BeVeg is a Law-firm-issued vegan symbol.

Global vegan trademark for products and services that do not use or exploit animals. Represented on every continent except Antarctica. BeVeg is a Law-firm-issued vegan symbol.

The CDC says about 75 percent of infectious diseases are of animal origin. Experts warn the next viral pandemic to erupt may be deadlier. What's the panacea?

This global catastrophe would not be happening if we lived in a plant-based world. We must evolve, if only for our own survival. It's time to make veganism go viral.”

— Carissa Kranz, Esq., Founder & CEO of BeVeg Global Vegan Certification

NEW YORK, NEW YORK, UNITED STATES, March 29, 2020 / — The deadly coronavirus, that is now plaguing humankind, has been traced back to a live meat market. So have other deadly global pandemics like SARS. It is believed Ebola is connected to the consumption of bushmeat, the meat of wild animals. E-coli and salmonella are connected to the presence of feces in the food system. A Consumer Reports study found that 100% of the hundreds of pounds of ground beef examined contained fecal matter. The exploitation of animals for meat has also resulted in other contagions deadly to humans: mad cow disease, swine flu (pigs), avian flu (birds), Spanish flu (farm animals), HIV (primates), etc. There is an undeniable link to animal exploitation for meat and deadly human pandemics.

This is a time for all of us to take a pause. What are we doing to ourselves and to this planet? Why has nearly everything shut down in the world except the very culprit of these viral pandemics: Slaughterhouses? Do we realize that in our quest for survival (grocery hoarding) we are feeding and funding the very industry that is known to give birth to these deadly viral pandemics?

COVID-19, dubbed the coronavirus, is an uncontained highly contagious global pandemic spreading at unprecedented rates. To prevent the spread of the virus, we are on heightened alert for germs and unsanitary conditions. We are wearing masks and gloves and wiping everything down with Clorox. We are isolating ourselves from others and in quarantine. Our hands are chapped because we’ve washed them so much. We are all working from home or out of jobs condemned to be home, watching the news dismayed as our world leaders put the world on lock down. We are witnessing the shut down of all non-essential businesses, flights cancelled, stay at home orders in effect, and state and country borders closing, all with the hopes of containing the virus.

With no apparent vaccine, no end in sight, and a death toll that climbs daily, people are panicking, stocking up on supplies and food, as they prepare to hunker down. As we hoard groceries and toilet paper, the virus continues to wreak havoc on human health and destabilize global economies. The Coronavirus has literally caused the world to shut down and panic. To distract the panic, the US Senate passes an unprecedented $2.2 trillion coronavirus stimulus package to save our economy from a Great Depression.

At what cost to lives, the environment, and our overall planetary wellbeing until will we stop heading down the same destructive path? A stimulus package and a vaccine (if found) is damage control. What’s the solution for a sustainable society? What do we need to do to protect our planet and our own well-being? The truth is, this global catastrophe would not be happening if we lived in a plant-based world.

History has shown us time and time again that slaughterhouses and “wet markets” are unsanitary cesspools for feces, blood, guts, disease, urine, and other bacteria to incubate and mutate into deadly human viruses. What else is there? What’s the next pandemic unleashed from animal exploitation for meat to wreak havoc on humankind? For centuries, deadly viruses traced back to animal farming and slaughter have plagued mankind. Is this the Law of Unintended Consequences in play? Is it worth taking any more chances?

Three quarters of infectious diseases are zoonotic spillovers. Just consider these deadly human conditions linked to animal exploitation that are responsible for the deaths of hundreds of millions if not billions of people:

—Coronavirus and SARs are traced to live meat markets, where animals sit alive in cages awaiting onsite slaughter once purchased. The slaughterhouse is a hot bed for viruses to jump from animals to humans and mutate into deadly human viruses.

—Ebola. E. Coli, MRSA, Salmonella, and Hepatitis are all viruses born out of slaughterhouse environments and/or the human exploitation of animals for meat.

—Swine flu strains repeatedly develop during the raising and slaughter of pigs for meat. Mad cow disease (VCJD), a fatal disease which destroys our brain and spinal cord is contracted from the exploitation of cows for meat. Avian flu strains repeatedly develop from the unsanitary conditions of raising and killing birds for meat. Notably, new avian flu outbreaks are happening presently in Turkey and the Philippines during the COVID-19 crisis.

—The Spanish flu, which killed 50-100 million people, and affected 500 million, or one-third of the world’s population, was an avian flu strain traced to an animal farm in Kansas.

—The HIV virus was introduced as a deadly human to human virus after coming into contact with contaminated Chimpanzee blood as we hunted them for meat.

—The measles (MeV), which infects 30 million people annually, and kills close to 200,000 globally, has traced origins to early civilization in the middle east when cattle was introduced to humans as livestock and farmed in close proximity.

—The bubonic plague, or Black Death, plagues humans when they eat animals infected by a deadly bacteria carried by fleas, or come into close contact with their bodily fluids.

—Smallpox, perhaps the deadliest pandemic to mankind, has increasing evidence from DNA and RNA sequencing that this is a zoonotic disease that jumped from animal to human. Some experts believed it originated as cowpox and mutated to evolve to what we call smallpox. It is estimated that the smallpox killed 300 million people in the twentieth century.

—Malaria is speculated to originate in humans from chicken farming before mosquitos became carriers to keep the virus alive.

—Nipah Virus (NiV) is a zoonotic virus transmitted from animals to humans, and can also be transmitted through contaminated food. Its origin is traced back to pig farms, and jumped to humans through sick pigs or close contact with their contaminated tissues.

—Listeria infection is a food borne bacterial illness most commonly caused by eating improperly processed deli meats and unpasteurized dairy products. Notably, processed meat is a group 1 carcinogen, according to the World Health Organization.

— The domestication of the horse led to the common cold virus that plagues humankind, while the domestication of chickens gave humans chickenpox, shingles, and various strains of the bird flu. The introduction of livestock cattle is responsible for the emergence of measles, smallpox, and tuberculosis.

The common denominator? Animal exploitation for meat. It kills us too.

When you make an industry over the exploitation and killing of animals for meat, there is no way to keep bodily fluids, blood, guts, and diseased conditions safe and sanitary for humans. We slaughter 3 billion animals a day and more than 1 trillion animals a year for meat. The industry and conditions required to raise this quantity of animals for slaughter and food is unsanitary, inhumane, diseased, and perhaps the greatest weapon of mass destruction. The death toll for us and them is unprecedented. When there’s a pandemic, they get systematically wiped out, while we scramble to find vaccines to survive. There’s no way around it. The business of exploiting and killing animals for food is a hot bed for highly contagious, deadly viral global pandemics.

History is repeating itself.

Yet, we are still feeding the industry demand. Grocery store shelves are out of meat, and the USDA is heroically assuring the public slaughterhouses will remain open. Do we realize the gravity of live meat markets and slaughterhouses to humankind? What’s the next global viral pandemic that will plague mankind?

Humanity should not build an economy that survives on the business of systematic mass murder of other beings. Humanity should be humane. We are abusing Mother Nature and ruining our natural habitat. This is about humanity’s relationship to nature, to people, to animals, and to the world. What is our true human nature? We are killing our planet, its natural habitat, and it’s inhabitants to raise and kill a trillion animals a year. Is this what human nature wishes to do to Mother Nature? Probably not. This is an intervention by mother nature. Humankind must take pause and listen. Humankind's relationship to nature and all kinds, and all kinds of things must become kind — our kind depends on it.

Every single human being’s life on this planet is at risk of contracting the deadly coronavirus, just by walking out their front door, and sharing airspace with the rest of the world.

This poses interesting legal questions. Are our personal civil liberties undermined so long as slaughterhouses remain open?

In an effort to prevent disease and food borne pathogens, and in the interest of global public health and safety, should the CDC order the closure of all live meat markets and address factory farm / factory slaughterhouse conditions? What’s our fundamental right to clean air, as the world walks around in masks? What’s our fundamental right to life, as the death toll increases? What’s our fundamental right to liberty, as we are forced into quarantine? Do we have rights as victims to the virus as we are deprived of life, liberty, and pursuit and economic property? Can we demand clean air laws, like we have smoke-free laws? Do vegans and vegetarians, which make up about 10% of our global population, have legal rights under the Clean Air Act or Environmental Protection Act? In fact, do we all have rights under these acts because we rely on these federal agencies to protect us? Who can be held accountable for infringing on our fundamental rights? After all, these highly contagious pandemics are viral air pollution. Do these unsanitary practices globally infringe on our fundamental personal civil liberties? Was that meal really worth it?

The Plant-Based Solution

We may not be able to rely on big industry businesses, big governments, or special interest politics to protect us. But that does not leave us helpless. As a species, we can help ourselves and our planet by returning to a plant-based diet. By decreasing our meat consumption, we end the demand for factory farming, live meat markets, factory slaughterhouses, and unsanitary local slaughterhouses (aka wet markets). Thereby, we eliminate the cesspool conditions that give birth to deadly viral pandemics that kill humans, and will continue to kill humans so long as these inhuman and unsanitary practices are in place.

Our survival as a planet depends on us ending the inevitable diseased viral conditions that exist and always will exist so long as slaughterhouses are big business. Let us not forget, this coronavirus crisis and financial crisis would not be happening if we did not exploit animals for meat. Likewise, our climate crisis would end if we stopped exploiting animals for meat. Millions of acres of our rainforests are cleared a year to keep up with consumer demand for meat consumption. It takes tremendous natural resources: land, food, and water to raise and slaughter more than a trillion animals a year for food.

A plant-based world is the panacea.

In our efforts to create a safe, sustainable world, it is important to define terms. Vegan is a term that is not legally defined but means containing no animal parts or by-products and produced without contact with any animal parts or by-products. Our survival as a species depends on sanitary food, beverages, and products that are not contaminated with diseased meat, bodily fluid, and fecal matter.

This is a time for consumers to demand honest ethical labeling. Supply chains must be held accountable to ethical, humane, sanitary standards. Likewise, the time is now for plant-based companies to be loud and proud of their food safety standards and veganism. They can do that by globally certifying that they are vegan with BeVeg, the world’s top vegan certification company. Certified vegan companies can show off the global trademark badge of honor!

“If you care about food safety and the sustainability of our planet, then let’s evolve… if only for our own survival, it's time to make veganism go viral. A Vaccine may end this pandemic, but veganism is the panacea.” — BeVeg campaign to end global pandemics

BeVeg International, is a law firm for vegan certification, founded by awarded-Super Lawyer Carissa Kranz. BeVeg is on a mission to globally and legally standardize vegan claims. BeVeg licenses use of its vegan symbol to companies and products with ethical business practices that do not partake in the exploitation of animals.

Proud of your conscious business practices? Want to show off the global vegan trademark that matters? Join the BeVeg campaign to make veganism viral, and certify vegan.

Carissa Kranz, Esq.
BeVeg Global Vegan Certification
+1 202-996-7999
email us here
Visit us on social media:

COVID-19 Crisis: Shut All Slaughterhouses

Source: EIN Presswire

Critical Path to Offer Free Online PR Services to Help Clients Navigate the Coronavirus Crisis

Adrian Lee - Managing Director, Critical Path

Adrian Lee – Managing Director, Critical Path

Critical Path - Public Relations & Corporate Affairs

Critical Path – Public Relations & Corporate Affairs

Critical Path to provide Business Continuity and Stakeholder Communications consulting to help clients navigate challenges caused by the COVID-19 pandemic.

COVID-19 presents unprecedented challenges to all organizations. We are helping our clients navigate through this crisis by providing 1-on-1 access to leading healthcare and crisis management experts.”

— Adrian Lee

SINGAPORE, March 29, 2020 / — 30th March, 2020 – Public relations and corporate affairs agency, Critical Path (, today announced that they will be offering free communications counsel through a series of webinars to help guide their stable of Southeast Asia clients through the COVID-19 (coronavirus) crisis.

The first webinar will take place in the first week of April and will be focused on Business Continuity and Stakeholder Communications.

“The COVID-19 pandemic presents totally new challenges to every type of organization, whether large or small, private and public sector. The goal of these online interactive sessions is to help our clients navigate through this period of crisis by providing them access to communications, business and health experts that can give them adequate guidance,” shares Adrian Lee, Managing Director, Critical Path.

“For the first webinar, we will be focusing on business continuity and stakeholder communications. In the face of a unique and significant crisis situation like COVID-19, an effective business continuity plan needs to be developed and activated, which then needs to be shared with all important stakeholders,” adds Lee.

For each webinar, Critical Path will engage the services of healthcare, business, technology experts, who will complement the Critical Path communications and crisis management team.

In April, the Critical Path consulting team will join forces with experts from leading Southeast Asian healthcare group, Merial Health, and financial holding and consulting group, Zenith Capital:

– Dr. Ardiansyah Bahar, CEO of Merial Health, will provide details about the COVID-19 pandemic, what to believe and what not to believe, and what business and HR leadership can do to ensure the safety of their employees.
– Zenith Capital and Critical Path consultants will then go through a Business Continuity checklist and also share best practices from their own first-hand experience dealing with and navigating through the coronavirus situation in China and Hong Kong.

“Merial Health is happy to take this opportunity to help organizations gain a better understanding of COVID-19 and the potential impact it may have on their operations. There is a lot of information and misinformation out there and it will be my job to help answer questions and give accurate guidance regarding important first steps and follow-up actions that need to be done to combat this pandemic,” says Dr. Bahar, CEO of Merial Health.

Dr. Bahar adds: “This webinar will help put participants in a better position to keep their business going as best as possible, but most importantly to keep their employees safe.”

About Critical Path
Critical Path is a full-service communications and consulting firm, catering for established global and national brands as well as promising start-ups. In addition to offering integrated communications, custom research and investor relations services, Critical Path also provides funding and market entry support. Critical Path has a presence in Asia, the United States, Europe, and the Middle East. For more information, visit

Jervis Teo
Critical Path
email us here
+65 6829 7000

Source: EIN Presswire

Prefabricated Modular Steel Panel Hospital Intensive Care Units (ICU's)

Intensive Care Units (ICU’s)

ICU Front View

Isolation Room with Negative Pressure HEPA Filtration & UV Light

Prefabricated Modular Steel Panel Hospital Intensive Care Units (ICU's) & Modular Isolation Rooms & Negative Pressure Rooms with HEPA Filter & UV Light Options

We have 330 million persons in the USA. In 12-18 months, 1% of the population (if tested) may be infected with COVID-19. If proper protocol is followed, millions of isolation units may be needed.””

— M.R. Secure Sales LLC Spokeman

MANALAPAN, NEW JERSEY, UNITED STATES, March 29, 2020 / — Panel Built has introduced Prefabricated Modular Steel Panel Hospital Intensive Care Units (ICU's) and Prefabricated Modular Hospital Isolation Rooms along with Negative Pressure Rooms, to help hospitals due to room shortages caused by the COVID-19 surge. Steel panel rooms have multiple uses and can be customized and adapted for for the individual hospital needs.
Panel Built, modular construction provider for 25 years, now offers a way for medical facilities to create and expand their infectious patient isolation areas with modular Isolation rooms. With the growing Coronavirus pandemic spreading across the United States and internationally, Panel Built’s modular isolation rooms are a convenient solution for hospitals that need to increase their single-occupancy, isolation space as quickly as possible. Using a panelized wall system, the isolation rooms are fully fabricated in Panel Built’s modular construction facilities. The components are then delivered and assembled on site. This design allows for prefabricated, quickly assembled isolation rooms that have fully customized layouts and designs.

Panel Built’s ICU's and isolation rooms offer options, (where situations warrant), for HVAC systems with fan filter units (FFUs) to keep the room at appropriate temperatures and constantly filter particles with HEPA filtration and UV light from the environment’s air supply with the numerous air exchanges per hour. Patient isolation rooms can be customized with a negative pressure environment for patients who may have an impaired immune system and may be a carrier for other infectious diseases that are airborne spread along with the droplet Coronavirus. Diseases such as TB, Measles, Mumps, Varicella and other respiratory infections fall into the airborne category. When the negative pressure isolation room is needed, the air pressure inside the isolation room is lower than entrance ante room to keep air flowing into the patient isolation room instead of out, keeping any contaminants or particles from escaping the room. All isolation rooms should be used in conjunction with proper staff and equipment sanitizing and hospital contamination control procedures.

Panel Built’s Steve Grzesik, Sales Manager Welded Steel Division, stated, "While Panel Built is a for-profit company, our first objective is to help our nation and others meet the challenge and help save lives. Our nation's largest hospitals and long term care centers will need all the isolation bed space they can get, and Panel Built is ready to help meet the need."

M.R. Secure Sales LLC spokesman stated the following, " There are 330 million persons in the USA. Predictions are, over the next 12-18 months, approximately 1% of the USA population (if tested) may be infected with the Coronavirus. If proper protocol is to be followed, millions of isolation rooms may be needed in the USA alone. The nations largest hospitals in total, may have fewer than several thousand isolation rooms. "
Panel Built was founded in 1995 by brothers Pat and Mike Kiernan, and began with the construction of pre-manufactured buildings. Today, Panel Built offers a complete line of custom modular offices, mezzanines, security booths, pre-assembled exterior buildings, and cleanrooms. Panel Built isolation rooms are designed 100% to customer specification and are delivered with components ready for installation. Panel Built’s main mission is, “Solving Our Customers’ Space Needs with Excellence and Great Customer Service.”

Isolation Room Brochure:

For more information, visit:

The New Generation in Modular Buildings, Enclosures & Mezzanines

Contact information:

Mike Rosenberg
M.R. Secure Sales
Limited Liability Company
Cell 732-491-5120

Steve Grzesik
Sales Manager Welded Steel Division,

Panel Built, Inc.
P.O. Box 2658, Blairsville, GA 30514
Office (706) 745-6540 TF (800) 636-3873 Fax (706) 745-1450

“M.R. Secure Sales LLC represents leaders in Modular Prefabricated Modular Steel Panel Hospital Intensive Care Units (ICU's) Isolation rooms and Negative Pressure Infectious Disease Isolation Rooms,Clean Rooms,Guard/Security/Parking Booths & Bus Shelters, Offsite Sustainable Construction of Steel and Concrete Multi-Story Modular Schools, Dorms, Condos, Town Houses, Senior Housing, Hotels, Retail Stores, Emergency Care Facilities, Equipment/Telecommunication Shelters, Modular Correctional Facilities, Modular Steel Police/Jail and Prison Cells,Modular Offices within in Factories and Warehouses, and Miscellaneous Metals and Custom Steel Railings and Stairs”

+1 732-491-5120
email us at
Visit us on social media:
Michael J Rosenberg
+1 732-491-5120

Michael J Rosenberg
+1 732-491-5120
email us here
Visit us on social media:

Source: EIN Presswire

God, Price Gouging, & YouTuber Mark Rober Inspired Us To Make Our Own Hand Sanitizer To Fight The Spread Of Coronavirus

EFX Sports Hand Sanitizer

EFX Sports Hand Sanitizer

Here's the story behind our hand sanitizer. Just trying to be a part of the solution to this crazy, life-altering dilemma we now find ourselves battling.

At that instant, the idea became obvious: Make our own hand sanitizer and give it to the public at highly reduced prices.”

— Brian Andrews

BILLINGS, MT, UNITED STATES, March 28, 2020 / — Sports Nutrition Company EFX Sports saw a major need in the marketplace due to consumer injustices caused by price gouging and after seeing a video by famous YouTuber Mark Rober. These things, along with a little nudging from God, moved them to do something to help stop the spread of Coronavirus.

Brian Andrews, President of EFX Sports said, “This pandemic is easily the most talked about topic in recent history. It dominates the news and the majority of conversations both on and off Social Media. Sadly, events like this also give some people the opportunity to try and take advantage of others.”

EFX Sports is a sports nutrition company that usually produces high-end supplements for athletes and bodybuilders. Even so, they realized they had the means to manufacture something that’s needed now more than ever before: hand sanitizer.

“As soon as this thing started, we noticed how some people were buying up hand sanitizer to try and cash in on everyone’s fear. They know that as supplies diminish something as common as hand sanitizer becomes very valuable”, states Mr. Andrews.

He further shared, “Through prayer, our company’s leadership felt called to help fight Coronavirus, but we didn’t know exactly how. Coincidentally, I happened to see a fantastic video recently posted by YouTuber Mark Rober where he explains how easily germs and viruses are spread between people. He said the key to slowing or stopping the transmission is having clean hands and not touching your face. At that instant, the idea became obvious: Make our own hand sanitizer and give it to the public at highly reduced prices.”

So far, the response has been overwhelming with calls and orders coming from all over the world. As a result, the production of EFX Sports Hand Sanitizer at their facility in Billings, Montana, All American Pharmaceutical, is running at 20 hours per day to meet demand.

For more information contact Brian Andrews via email,, or visit their website at

Brian Andrews
EFX Sports
+1 888-238-1864
email us here
Visit us on social media:

EFX Sports Hand Sanitizer

Source: EIN Presswire

Steven F. Weiner, MD Introduces Facial Ultrasound to Improve Safety with Cosmetic Facial Filler Treatments

Superior Orbital Artery at The Superior Orbital Notch

Dr. Steven F. Weiner with Dr. Leonie Schelke and Dr. Oscar Janssen at Instructor Training

Ultrasound of Temple Area Showing Superficial Temporal Artery, Temporalis and Intermediate Temporal Fat Pad

Using ultrasound, Dr. Weiner is able to visualize facial vasculature, previous filler placement, and can evaluate complications from prior filler injections.

Using ultrasound in facial aesthetics will soon become the gold standard for safe filler injections. Ultrasound is particularly valuable in treating filler complications.”

— Steven F. Weiner, MD

SANTA ROSA BEACH, FLORIDA, UNITED STATES, March 28, 2020 / — Dr. Steven F. Weiner, a Facial Plastic Surgeon in Santa Rosa Beach, Florida, becomes one of the first physicians to bring facial ultrasound into a cosmetic practice in the United States. While ultrasound has been used by most of the medical specialties to assist in anatomical visualization and assisted injections, the U.S. facial aesthetics industry has not adopted it's use…until now. The practice of using ultrasound for facial anatomy and fillers was introduced in 2010 by a group of physicians in Amsterdam, Dr. Leonie Schelke (Cosmetic Physician), Dr. Oscar Janssen (Radiologist), Dr. Peter Velthuis (Dermatologist), and Dr. Constantijn Pleiter (Radiologist). This group of physicians created the training program, the worldwide leader in ultrasound training for facial aesthetics. In 2019, Dr. Weiner attended their instructor course in Amsterdam.

"Using ultrasound in facial aesthetics will become the gold standard for safe filler injections" says Dr. Weiner. "While many providers are very proficient in facial anatomy, there are anatomic variations, particularly vascular anatomy, which can only be determined using ultrasound during a patient's office evaluation and treatment." One of the rare complications of filler injections is a vascular occlusion, an obstruction of an artery caused by injection of filler within the vessel. Ultrasound use in the physician's office is a painless, noninvasive procedure that can be used to evaluate the critical vascular structures such as the facial artery, superficial temporal artery, infraorbital artery, superior and inferior labial artery, supratrochlear and supraorbital arteries, angular artery and dorsal nasal artery. "Routine use of ultrasound for every filler injection is not necessary, but if there is any question by the provider of the vascularity in critical areas, ultrasound can be helpful."

In the rare case of vascular occlusion, ultrasound is able to determine the area of blockage and to visualize the "pocket of filler". If the offending filler injected is a hyaluronic acid (HA) filler, there is a reversal agent called hyaluronidase, which can be injected to dissolve the filler. "While hyaluronidase can be injected in the general vicinity of occlusion, using ultrasound guidance allows for more specific and directed injections and most likely, better outcomes" states Dr. Weiner. Another complications of fillers, such as delayed swelling, nodules, or granulomas, can also be visualized using facial ultrasound. These complications often will require therapeutic injections which can be guided using ultrasound.

Facial ultrasound can be used as an educational tool for both providers and patients, to highlight anatomy, and to visualize previously placed filler. Often patients are interested in seeing whether past filler is still present. Conversely, Dr. Weiner has had many cases of filler still present up to 10 years after injection, particularly around the eyes, of HA filler that typically lasts 1 year.

The future of facial ultrasound adoption in the U.S. will grow exponentially over the next couple years. Dr. Weiner is already planning training courses at conferences including the Los Angeles Multi-Specialty Cosmetic Association (LAMCA) and Aesthetic Next 2. Future trainings will be announced in the near future and private trainings can be arranged as well by calling his office: 850.622.1214.

Dr. Weiner positions his practice, The Aesthetic Clinique, as one of the most technologically advanced cosmetic centers in the United States. Dr. Weiner lectures and trains worldwide on advanced injection techniques and aesthetic technologies. The Aesthetic Clinique was awarded the Best Aesthetic Practice in the U.S. in 2018 at The Aesthetic Show. In 2019 and 2020, The Aesthetic Clinique was voted Best Medspa and Best Doctor from The Best in Destin awards. He is one of the world's authorities on Radiofrequency Microneedling and recently published the most comprehensive review of the technology and studies in the Facial Plastic Surgery Clinics of North America. He was recently highlighted on "The Doctors Show" for his trademarked "reJAWvenation" technique for jawline rejuvenation using dermal fillers. Dr. Weiner has over 26 years of experience in the aesthetic industry.

Steven F Weiner
The Aesthetic Clinique
+1 850-622-1214
email us here
Visit us on social media:

Source: EIN Presswire

Vitro Biopharma First Quarter ended January 31st 2020 Financial Results of Operations

Vitro Biopharma is pleased to announce a record 1st comparative quarter in Total Revenues of $225,921 vs $192,895 an increase of 17% versus last year.

Vitro Diagnostics Inc. (OTCMKTS:VODG)

Vitro is pleased to have recently been recognized by Bioinformant as "a Company Tracking the Coronavirus".”

— Dr. James Musick

GOLDEN, CO, USA, March 28, 2020 / — Vitro Biopharma First Quarter ended January 31st 2020 Financial Results of Operations

Golden, Colorado-March 26, 2020-Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced its 1st quarter ended January 31st, 2020 financial results of operations.

Vitro Diagnostics Inc. (“Vitro Biopharma”) is pleased to announce a record 1st comparative quarter in Total Revenues. Vitro Biopharma recorded 1st quarter revenues of $225,921 vs $192,895 an increase of 17% over the same comparative quarter last year. In addition, Stem Cell treatments accounted for 74% of the revenues up from 71% of the revenues in the prior comparative quarter last year. Current quarter stem cell revenues were $167,750 for the 1st quarter ended January 31, 2020 vs $137,123 for the first quarter ended January 31, 2019.

The company’s gross profit margins improved to 75% up from 73% in the comparative prior year’s quarter. Gross margin improvement is in line with the strategic direction of the company to expand the market of its flagship product AlloRx™ Stem Cells. The company’s clean-room lab expansion last year and expanded Stem Cell manufacturing using its patent-pending cell line, has increased efficiencies and lowered production costs.

Overall operating expenses increased in the quarter to $193,385 from $147,398 in the prior year’s comparative quarter. The increase in expenses reflects additional investment as the Company expands its capability to service its strategic direction of offshore Stem Cell treatments while also expanding into US markets. The company expended additional resources on external consultants supporting our regulatory status in maintaining ISO9001 & ISO13485 certifications, expanding our efforts to approach US markets through FDA filings and advancement of existing patent filings.

The company’s first quarter is its most seasonal quarter as the period between Thanksgiving and the New Year is slow for all the company’s revenue lines of Nutra Vivo™/STEMulize, AlloRx™ Stem Cells, private labeled InfiniVive MD™ Stem Cell Serum and our core research products.

During the quarter the company achieved and pursed the following company objectives

• Series A Convertible Preferred Stock Offering:

During the quarter the company commenced a Series A Convertible Preferred Stock offering to accredited investors under the SEC Regulation D exemption. The preferred Stock is priced at $25 per share which is convertible at $0.25 cents per share for a total of 100 shares. The minimum investment is $50,000 per unit. The company sold $450,000 of the Series A Convertible Preferred Stock during the quarter. The company has additional interest in the offering and subsequent to the quarter has sold an additional $50,000 unit for a total to date of $500,000. The company has additional interested parties for approximately $200,000. The offering is for a total of $1,000,000.

• Expansion of revenues & results from the clinical trials in the Cayman Islands:

Our partnership with DVCStem in the Cayman Islands continued to advance through treatment of new & previous patients. This IRB-approved protocol targets patients with inflammatory conditions including multiple sclerosis, systemic inflammation and new indications including Crohn's disease, Alzheimer’s disease and COPD. To date we have treated 60 patients including repeat treatments. There have been no serious adverse events and we continue to gain evidence of efficacy. One of the initial MS patients has now received a second transplant of our AlloRx™ Stem Cells and he has reported significant therapeutic benefits of both the initial and subsequent therapy. He had received an earlier transplant of adipose-derived MSCs that was effective, but the improvement lasted 3 months while AlloRx™ Stem Cell therapy lasted 18 months. We had predicted such a clinical outcome based on significantly higher potency of umbilical cord MSCS compared to those derived from adipose tissue or bone marrow. The Crohn’s disease patient showed significant improvement as did both the AD & COPD patients.

• Further Expansion into US Markets-FDA IND:

The strategic development of our stem cell therapies involves pursuit of both offshore and domestic markets. The partnership with DVC Stem, our IRB-approved trial in the Bahamas together with other strategic opportunities represent offshore operations & prospects. During Q1 2020, we initiated expansion into US therapeutic markets through development of an Investigational New Drug (IND) application for submission to FDA. Once approved, an IND allows the conduct of clinical trials for specific medical conditions in the US.

Given the current COVID-19 pandemic, our initial IND application is for use of AlloRx™ Stem Cells in treatment of Coronavirus infections. This is supported by clinical studies showing that 17 critically ill patients responded favorably to IV infusion of umbilical cord-derived MSCs. All patients were receiving assisted ventilation but 3 days following stem cell therapy, were removed from ventilators and subsequently discharged from the hospital. We are pursuing discussions with FDA to establish the appropriate regulatory pathway and expedited review options given the current emergency circumstances. (See Subsequent Events, below, for additional discussion of our COVID-19 response.) Once our initial IND is in place, we have plans for additional INDs for stem cell therapy of musculoskeletal conditions and Alzheimer’s disease.

• PR Medica Opportunity:

We have received an initial order of AlloRx™ Stem Cells for testing purposes by PR Medica located in Cabo San Lucas. Given successful test results, we anticipate subsequent new revenue generation from this customer.

• InfiniVive MD™ Stem Cell Serum:

Vitro Biopharma’s cosmetic topical stem cell serum is being distributed by InfiniVive MD™ into cosmetic clinics that are providing the topical treatment as a beautification product. To date the company’s product is being offered in 10 cosmetic clinics.

Our partner, Dr Jack Zamora, MD was a keynote speaker at a master session at the American Academy of Cosmetic Surgery annual meeting in late February. The topic of his presentation was “Topical Stem Cells, Exosomes and Conditioned Media Serums in Aesthetics.” This was the official launch of the InfiniVive-MD platform including: Dailey Serum, Stem Cell Serum 2.0 & Exosomes within the product line. Vitro Biopharma will manufacture & private label these new products for distribution in the US. We anticipate InfiniVive MD growth, development and revenues to mirror the development of Apyx subdermal plasma skin tightening as a cosmetic treatment and technique that has gone global.

• Research and Development, Facility Expansion & Patent Prosecution

Our core research product sales continued to expand in Q1 2020. Our facility expansion continued with addition of manufacturing capacity and development of plans to add operational facility to increase outputs further by 100% or more. We were also in discussions with the USPTO regarding our pending patents for our novel stem cell therapy and stem cell activation technology. We continue to work closely with our examiner and have established communication channels to facilitate awards of these patents.

• SUBSEQUENT EVENTS: COVID-19 Opportunity and Risks

The COVD-19 pandemic is a significant obstacle for all business. However, Vitro Biopharma is uniquely positioned since we have a potential effective therapy. This is based on 3 independent reports showing efficacy of stem cell therapy in 17 COVID-19 patients. All were treated with IV umbilical cord MSCs comparable to AlloRx™ Stem Cells and all 17 required respiratory assistance but within 3-4 days of treatment, were able to breath without ventilators and were discharged within 14 days. On the contrary, untreated patients on ventilators have death rates of 50% or more. We have received a formal request to supply AlloRx™ Stem Cells for compassionate use from a major university medical center and several other potential clinical partners have also expressed interest in using our cells to treat COVID-19 patients. We are presently working with the FDA to gain authority to begin clinical testing in the US. We are currently assessing the overall financial impact of the COVID-19 pandemic on our business, but this depends on overall control of the pandemic. There have been no staff layoffs and our workers are considered essential since we conduct essential research to the COVID-19 response.

Dr. Jim Musick, CEO of Vitro Biopharma, said, “We are very pleased with the increased revenue growth during our first quarter 2020 compared to the prior year However all our resources are currently focused on the emergency response to the COVID-19 pandemic and increasing our inventory of AlloRx to satisfy anticipated emergency demand to treat critically ill COVID-19 patients.” The Company is working to get expedited clinical trial approvals to sell our AlloRx Stem Cells to hospitals coping with the pandemic. Vitro is pleased to have recently been recognized by Bioinformant as "a Company Tracking the Coronavirus". We anticipate clinical progress in the effectiveness of our stem cell therapies while expecting to see a reduction in our offshore and cosmetic revenues for the next quarter or two. The company is in a good cash position to weather this storm and simultaneously advance its AlloRx stem cell therapies into clinical trials.

In summary, Vitro Biopharma is advancing as a key player in regenerative medicine with 10+years’ experience in the development and commercialization of stem cell products for research, recognized by a Best in Practice Technology Innovation Leadership award for Stem Cell Tools and Technology and a growing track record of successful translation to therapy. We are leveraging our proprietary technology platform to the establishment of international Stem Cell Centers of Excellence and regulatory approvals in the US and worldwide.

Sincerely yours,

James R. Musick, PhD.
President, CEO & Chairman of the Board

Forward-Looking Statements

Statements herein regarding financial performance have not yet been reported to the SEC nor reviewed by the Company’s auditors. Certain statements contained herein and subsequent statements made by and on behalf of the Company, whether oral or written may contain “forward-looking statements”. Such forward looking statements are identified by words such as “intends,” “anticipates,” “believes,” “expects” and “hopes” and include, without limitation, statements regarding the Company’s plan of business operations, product research and development activities, potential contractual arrangements, receipt of working capital, anticipated revenues and related expenditures. Factors that could cause actual results to differ materially include, among others, acceptability of the Company’s products in the market place, general economic conditions, receipt of additional working capital, the overall state of the biotechnology industry and other factors set forth in the Company’s filings with the Securities and Exchange Commission. Most of these factors are outside the control of the Company. Investors are cautioned not to put undue reliance on forward-looking statements. Except as otherwise required by applicable securities statutes or regulations, the Company disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.

Dr. James Musick
Chief Executive Officer
Vitro BioPharma
(303) 999-2130 Ext. 3

Source: Vitro Diagnostics, Inc.

John Evans
Vitro BioPharma
+1 303-601-7855
email us here

Source: EIN Presswire

Could Washing Our Noses Help Prevent Coronavirus-19? Renowned Nasal Surgeon, Dr. Robert Kotler, Believes It Could

Acclaimed Plastic Surgeon, Robert Kotler

Should We Not Be Attacking the Enemy’s First Hiding Place?

LOS ANGELES, CA, UNITED STATES, March 28, 2020 / — Robert Kotler, MD, FACS, Beverly Hills super-specialist in nasal cosmetic and reconstructive surgery, suspects we may be missing an opportunity to destroy the virus before it causes the worst consequence, destruction of the lungs and death.

“We may be forgetting about the nose as an accessible first line of defense”, notes Kotler, a UCLA faculty member and former Major, US Army Medical Corps. “Handwashing with soap works to reduce the likelihood of the virus taking hold in the body. Might soap perform equally well inside the nose?”

FACT: Soap is effective because each Coronavirus-19 virus wears a fat-laden outer covering. Soap destroys the fatty layer; virus disabled and dies. It can work its magic elsewhere.

FACT: CV-19 is a disease of the lungs. The nasal passages are the portal of entry, carrying air flow to the lungs. Can we stop the virus before it multiplies and invades the lungs?

FACT: Current testing for presence of the virus is done by swabbing the interior of the nose.

FACT: French Ear, Nose and Throat specialists have observed that some CV-19 patients report that loss of smell and taste were among the very first symptoms experienced.

This likely confirms infestation of the nose by a significant virus population. Enough to damage the smell sensors housed within the nose.

FACT: A dab of soapy lather into each nostril is not unsafe, nor unknown. Nasal surgeons, prior to fashioning internal incisions, habitually wash/disinfect the inside of the nose, particularly the vestibule, the visible and accessible portion of the nose’s interior. The nasal lining is known to very tolerable to a variety of soapy disinfectants.

A recommended plan:

Immediately initiate clinical trials to determine if those patients whose nasal swab testing was positive for CV-19 will show no or minimal residual virus after a prescribed several- day nasal wash routine.

If such testing demonstrates effectiveness of nose washing, add it to the current official prevention recommendations. Other adjuncts, such as special nasal irrigations, may also be tested. Even a variety of soap brands.

Dr. Kotler wonders if perhaps “Wash your hands and wash your nose” might be our new anti-CV-19 mantra.

Contact: Robert Kotler, MD, FACS

310- 927-5724, 9-9 Pacific Daylight Time

Aurora DeRose
Michael Levine Media
+1 951-870-0099
email us here

Source: EIN Presswire

As Coronavirus Grows, Gun Sales Rise – An Alternative Self Defense Option for Everyone Does Exist

Reflex Protect®, offers a self-defense spray that empowers people to be their own first responder

Be Your Own First Responder

Citizens worry about violence, but not everyone wants to own a gun. Reflex Protect®, is a self-defense spray allowing people to be their own first responder.

A non-lethal solution that addresses violence, but in a non-violent way.”

— Our goal is to bring peace of mind to the public

MISSOULA, MONTANA, UNITED STATES , March 28, 2020 / — Sales of guns and ammunition are way up due to fears about Coronavirus. reported transactions are up 68%. People are living in fear of violence and looking for solutions, but not everyone feels comfortable owning a gun. Reflex Protect® offers a proven non-lethal, non-violent alternative.

“Our Presidia Gel® is delivered through a patented technology spray head, that easily and accurately shoots the perpetrator up to 20 feet away and delivers a rapid onset of temporary blindness and pain, debilitating the attacker until help arrives,” says Joe Anderson, Co-Founder and President. “If you can use a spray cleaner you can use Reflex Protect,” he says.

About Joe Anderson. In 1993 on a Thursday, just before 3pm, a gunman entered Joe Anderson’s former workplace in San Francisco and killed 9 of his friends and colleagues. For years all he could think about was “how can we stop this from ever happening again?” “When my friend Steve Mangold came to me with this product, I thought, “I wish this had been in the receptionist’s hands 25 years earlier; it might have changed everything.”

Mangold and Anderson started Reflex Protect and developed a non-lethal solution that addresses violence, but in a non-violent way. “Our goal now is that every receptionist, front line worker, ER triage nurse and teacher can feel empowered and protected – without having to face the use of violent force,” says Anderson.

Joe is available for interviews and to discuss:
• Specific safety tips for home, work and public spaces
• The “gun vs. no gun” safety debate in light of Coronavirus

Karen Leland
Reflex Protect
+1 415-260-4615
email us here
Visit us on social media:

Source: EIN Presswire


Performing & Creative Arts Classes

Performing & Creative Arts Classes

Performing & Creative Arts Classes

Performing & Creative Arts Classes

London-based arts company City Academy opens its doors to thank key health workers

We are extremely grateful for all those working across the health service. As a gesture we are welcoming NHS staff, care-workers and those in private practice to join in our creative courses, on us.”

— Michael Ward

LONDON, UNITED KINGDOM, March 28, 2020 / — Performing and Creative Arts company City Academy is offering each NHS and care-home worker £500 worth of free arts courses. Inspired by the valiant efforts of staff on the front line fighting COVID-19, the London-based arts company has made their full range of short courses – up to a total value of £500 – available at no charge.

The offer encompasses day and evening arts courses in a wide range of subjects, that include; Acting, Singing, Dance, Filmmaking, Musical Theatre, Comedy, Writing, Life Skills, Photography and more. City Academy courses take place at over 50 venues in Central London and will resume from June/July 2020. To claim the offer, NHS and private practise staff as well as care-workers should contact the City Academy team by emailing with their name, job title and ID card.

Coming together in a creative setting to do what you love is proven to help alleviate stress and enhance mental and physical well-being. The link between health and the arts was made clear by an all parliamentary group in a recent report. Creative Health: The Arts for Health and Wellbeing states that “Participatory arts activities help to alleviate anxiety, depression and stress both within and outside of work.”

City Academy’s Managing Director Michael Ward said, “All of us at City Academy are extremely grateful for all those working across the health service to tackle this terrible virus. As a gesture we are welcoming NHS staff, care-workers and those in private practice to join in our creative courses, on us."

Offer Details
Up to £500 credit per person for NHS, care home and private practise staff.
Valid on all courses (excludes ongoing groups and business/groups offering).
Valid for a full 18 months expiring 1st October 2021.
The offer is non-transferable and non-refundable.
Select number of complimentary NHS places per course.
See our full range of courses online at
About City Academy

City Academy is a performing and creative arts company that provides the space for individuals to invite creativity into their day. Working across 50 central London venues and 200 industry professionals, the company welcomes 30,000 students across 3000 courses each year. City Academy’s aim is to provide the skills and practical experience for adults to realise their ambitions in the creative and performing arts.

Quick facts:
City Academy was founded in 2007 by Michael Ward and Susan Young.
Courses are led by industry experts including writers, filmmakers, choreographers, artists and performers.
Partner venues include Sadler’s Wells, Old Diorama Theatre, Mountview and the English National Ballet.
The ‘Creative Health: The Arts for Health and Wellbeing’ all parliamentary report was published July 2017 is available at

Contact Details

Company: City Academy
Contact: Peter Spring, Director
Tel: 020 7042 8833

Twitter: @CityAcademyUK
Instagram: @CityAcademyUK

Michael Ward
City Academy
+44 20 7042 8833
email us here

Source: EIN Presswire

China Cosmetics Market Outlook 2025- by Goldstein Research

The low-to-mid priced products are majorly offered by the local players in China, whereas the foreign players have focus on the high end segment.

NEW YORK, NY, UNITED STATES OF AMERICA, March 28, 2020 / — China Cosmetics Market Outlook 2025

According to the Goldstein Research report , In terms of competition among the players in cosmetic industry, the low-to-mid priced products are majorly offered by the local players in China, whereas the foreign players have focus on the high end segment.

China cosmetics industry is the fastest growing market in the world over the past few years. the consumer’s attitude towards cosmetics market has drastically changed in China. In present scenario consumers in China tends to get less influenced by the media advertisement & prefer to gather information of a product through various sources.

Report is available at:-

Covered in this China Cosmetics Market Report are
“China Cosmetics Market Outlook 2025” by Goldstein Research contains detailed overview of the China Cosmetics Market in terms of market segmentation by analysis basis, therapy type and geography. The Report highlights the competitive outlook of major global players that includes the business strategies, product portfolio, revenue distribution, financial analysis, R&D activities, and investments. The in-depth analysis of China Cosmetics Market report will help the clients to assess their business strategies as per the competitive environment in the market space.

Major players covered in this China Cosmetics Market report are :

the Estée Lauder Companies Inc.
Ralph Lauren Corporation
Avon Products Inc.
The Procter & Gamble Company
Unilever PLC
Bee & Flower

Request for Sample Report at:-

Further, China Cosmetics Market Report encompasses the major trends & opportunities, market dynamics and other growth factors of the market. The China Cosmetics Market outlook also comprises of key challenges, risk analysis, BPS analysis, SWOT Analysis and Market Attractiveness. The report also highlights the expert analysis to provide a complete overview of the market including the PESTLE analysis of each region and country.
About Goldstein Research
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview.
Our analysts working on chemicals construction to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

Contact for more Info:
Steve Blade
(Global Sales Head)
USA: + 1-646-568-7747
Canada: 1-437-886-1181
UK: +44-203-318-6627

Steve blade
Goldstein Research
+1 6465687747
email us here

Steve Blades
Goldstein Research
+1 646-568-7747
email us here
Visit us on social media:

Source: EIN Presswire